[1]
Roszkowski M.: Nowotwory ośrodkowego układu nerwowego. [w:] Neurologia wieku rozwojowego. Steinborn B. i wsp. [red.], PZWL, Warszawa 2017.
[2]
Perek D., Roszkowski M.: Nowotwory ośrodkowego układu nerwowego u dzieci. Diagnostyka i leczenie. Fundacja Neuronet, Warszawa 2006.
[3]
Duong L.M., McCarthy B.J., McLendon R.E., et al.: Descriptive epidemi-ology of malignant and nonmalignant primary spinal cord, spinal menin-ges, and cauda equina tumors, United States, 2004–2007. Cancer 2012; 118 (17): 4220–4227.
[4]
Szathmari A., Zerah M., Vinchon M. et. al.: Ependymoma of the spinal cord In children: A Retrospective French Study. World Neurosurg 2019 Mar 12. [Epub ahead of print].
[5]
Abd-El-Barr M.M., Huang K.T., Moses Z.B.,et al.: Recent advances in intradural spinal tumors. Neuro Oncol 2018; 20(6): 729–742.
[6]
Sofuoğlu Ö.E., Abdallah A.: Pediatric Spinal Ependymomas. Med Sci Monit 2018; 24: 7072–7089.
[7]
Chakravorty A., Frydenberg E., Shein T.T., et al.: Multifocal intradural extramedullary anaplastic ependymoma of the spine. J Spine Surg 2017; 3(4): 727–731.
[8]
Olsen T.K., Gorunova L., Meling T.R., et al.: Genomic characterization of ependymomas reveals 6q loss as the most common aberration. Oncol Rep 2014; 32 (2): 483–490.
[9]
Liu X., Sun B., Xu Q., et al.: Outcomes in treatment for primary spinal anaplastic ependymomas: a retrospective series of 20 patients. J Neu-rosurg Spine 2013; 19(1): 3–11.
[10]
Ronthal M.: Bóle szyi i kończyn górnych. [w:] Neurologia w medycynie klinicznej. Bradley W.G., Daroff R.B., Fenichel G.M. et al. [red.], Czelej, Lublin 2006.
[11]
McCormick P.C, Fetell M.R., Rowland L.P. Guzy rdzenia kręgowego. [w:] Neurologia w praktyce klinicznej. Rowland L.P. [red.], Urban&Partner, Wrocław 2004.
[12]
Cho JC., Miller A., Kettner NW.: Cervical ependymoma in a male adoles-cent with neck and back pain. J Manipulative Physiol Ther 2009; 32(8): 695–700.
[13]
Feldman WB., Clark AJ., Safaee M., et al.: Tumor control after surgery for spinal myxopapillary ependymomas: Distinct outcomes in adults versus children (A systematic review) J Neurosurg Spine 2013; 19 (4): 471–476.
[14]
Chamberlain M.C.: Etoposide for recurrent spinal cord ependymoma. Neurology 2002; 58 (8): 1310–1311.
[15]
Fakhrai N. Nephytou P., Dieckmann K. et al.: Recurrent spinal ependy-moma showing partial remission under Imatinib. Acta Neurochir 2004; 146 (11): 1255–1258.
[16]
Kim K.T., Lee C.H., Chung C.K., et al.: Is NF2 a Key Player of the Differen-tially Expressed Gene Between Spinal Cord Ependymoma and Intracra-nial Ependymoma? World Neurosurg 2018; 118: 906–917.
, Magdalena Dudzińska1
Scholar Google
PubMed